4,368
Views
3
CrossRef citations to date
0
Altmetric
Articles

Formulation and evaluation of niosomes-based chlorpheniramine gel for the treatment of mild to moderate skin allergy

, , , , , , , , & show all
Pages 467-495 | Received 24 Mar 2022, Accepted 21 Jun 2022, Published online: 19 Jul 2022

References

  • Gyati SA, Abhay A, Davinder S, et al. Etodolac containing topical niosomal gel: Formulation development and evaluation. J Drug Deliv. 2016;2016:9324567.
  • Nicoli S, Colombo P, Santi P. Release and permeation kinetics of caffeine from bioadhesive transdermal films. AAPS J. 2005;7(1):E218–223.
  • Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res. 1996;13(12):1765–1769.
  • Tymes NW, Shah VP, Skelly JP. In-vitro profile of oestradiol transdermal therapeutic systems. J Pharm Sci. 1990;79(7):601–602.
  • Zhai H, Maibach H. Occlusion versus skin barrier function. Skin Res Technol. 2002;8(1):1–6.
  • Misra AN. Controlled and novel drug delivery. In: Jain NK, editors. Transdermal drug delivery. New Delhi: CBS Publishers; 1997. 8(1)100–101.
  • Heather AE. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23–33.
  • Ayoub RK, Murtaza G, Imran M, et al. Formulation and permeation kinetic studies of flurbiprofen gel. Trop J Pharm Res. 2015;14(2):195–203.
  • Ozeki T, Yuasa H, Kanaya Y. Application of carbopol to controlled release preperations I. Carbopol as a novel coating material. Int J Pharm. 2000;199(1):77–83.
  • Yahagi R, Machida Y, Onishi H, et al. Mucoadhesive suppositories of ramasetron hydrochloride utilising carbopol. Int J Pharm. 2000;193(2):205–212.
  • Macedo T, Block LH, Shukla AJ. Release of tolmetin from carbomer gel systems. Drug Dev Ind Pharm. 1993;19(8):887–902.
  • Parson ME, Ganellin CR. Histamine and its receptors. Brit J Pharmacol. 2006;147(S1):S127–S135.
  • Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
  • Ceschel GC, Maffei P, Gentile M. Design and evaluation of a new transdermal formulation containing chlorpheniramine maleate. Drug Dev Ind Pharm. 1999;25(9):1035–1039.
  • Balata GF, Shamardl AM. Formulation of chlorpheniramine maleate in span 60/tween20 based organogels for transdermal delivery. JIPBS. 2017;4(1):49–57.
  • Fireman S, Toledano O, Neimann K, et al. A look at emerging delivery systems for topical drug products. Dermatol Ther. 2011;24(5):477–488.
  • Korting HC, Schäfer-Korting M. Carriers in the topical treatment of skin disease. HandbExpPharmacol. 2010;197(1):435–468.
  • Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv. 2009;6(8):813–825.
  • Bayindir ZS, Yuksel N. Provesicles as novel drug delivery systems. Curr Pharm Biotechnol. 2015;16(4):344–364.
  • El-Badry M, Fetih G, Fathalla D, et al. Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation. Pharm Dev Technol. 2015;20(7):820–826.
  • Jacob S, Nair AB, Al-Dhubiab BE. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition. J Liposome Res. 2017;27(4):283–292.
  • Varghese V, Vitta P, Bakshi V, et al. Niosomes of primaquine: effect of sorbitan esters (spans) on the vesicular physical characteristics. Indian Drugs. 2004;41(2):101–103.
  • VardeNeha M, ThakorNamita M, SiniSrendran C. Shah viral H. Formulation optimisation and evaluation of liposomal gel of prednisolone by applying statistical des. IJRPB. 2013;1(2):180–187.
  • Ravalika V, Sailaja AK. Formulation and evaluation of etoricoxib noisome by thin film hydration technique and ether injection method. Nano Biomed Eng. 2017;9(3):242–248.
  • Zhang F. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and eudragit FS. Drug Dev Ind Pharm. 2016;42(4):563–571.
  • Javed H, Shah SNH, Iqbal MF. Formulation development and evaluation of diphenhydramine nasal nano-emulgel. AAPSPharmSci’Tech. 2018;19(4):1730–1743.
  • Jaiswal PH, Dr. Gujarathi NA, Dr.Rane BR, Dr., et al. Formulation of niosomal gel of diclofenac sodium and its in-VitroCharacterization. IJPPR Human. 2016;6(4):585–600.
  • Bhattacharya SA, Prajapati BG. Formulation, design and development of niosome based topical gel for skin cancer. Med Clin Res. 2017;2(2):1–23.
  • Riaz R, Shah SNH, Javed H, et al. Development and evaluation of microsponge based chlorpheniramine maleate gel formulation. Lat Am J Pharm. 2017;36(10):2028–2036.
  • Ruan G, Feng SS. Preparation and characterisation of poly (lactic acid) poly (ethylene glycol)–poly (lactic acid) (PLA–PEG–PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003;24(27):5037–5044.
  • Goyal G, Garg T, Malik B, et al. Development and characterisation of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015;22(8):1027–1042.
  • Fathalla D, Abdel-Mageed A, Abdel-Hamid A, et al. In-vitro and in-vivo evaluation of niosomal gel containing aceclofenac for sustained drug delivery. IJPSR. 2014;1(1):105.
  • Mandal S, Mandal SS, Sawant KK. Design and development of microemulsion drug delivery system of atorvastatin and study its intestinal permeability in rats. Int J Drug Deliv. 2010;2(1):69–75.
  • Obata Y, Ashitaka Y, Kikuchi S, et al. Statistical approach to the development of a transdermal delivery system for ondansetron. Int J Pharm. 2010;399(1–2):87–93.
  • Nair A, Jacob S, Al-Dhubiab B, et al. Basic considerations in the dermatokinetics of topical formulations. Braz J Pharm Sci. 2013;49(3):423–434.
  • Sekhar KC, Naidu KV, Vishnu YN, et al. Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches. Drug Deliv. 2008;15(3):185–191.
  • Oryan A, Zaker SR. Effects if topical application of honey on cutaneous wound healing in rabbit. Zentralbl Veterinarmed A. 1998;45(3):181–188.
  • Shinde UA, Kanojiya SS. 2014 SerratiopeptidaseNiosomal gel with potential in topical delivery. J Pharm. 2014;2014(1):1–9.
  • Iman IS, Nadia AS, AbdouEbtsam M. Formulation and stability study of chlorpheniramine maleate transdermal patch. AJP. 2010;4(1):17–23. S
  • Shan X, Chen L, Yuan Y, et al. Quantitative analysis of haemoglobin content in polymeric nanoparticles as blood substitutes using Fourier transform infra-red spectroscopy. J Mater Sci Mater Med. 2010;21(1):241–249.
  • Khan MI, Madni A, Ahmad S, et al. Formulation design and characterisation of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Brazilian JPS. 2015;51(3):608–615.
  • Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul. 1995;12(3):229–246.
  • Balakrishnan P, Shanmugam S, Lee WS, et al. Formulation and in vitro assessment of minoxidilniosomes for enhanced skin delivery. Int J Pharm. 2009;377(1-2):1–8.
  • Korchowiec B, Paluch M, Corvis Y, et al. Langmuir film approach to elucidating interactions in lipid membranes: 1, 2-dipalmitoyl glycero3phosphoethanolamine cholesterol metal cation systems. Chem Phys Lipids. 2006;144(2):127–136.
  • Finean JB. Interaction between cholesterol and phospholipid in hydrated bilayers. Chem Phys Lip. 1990;54(3–4):147–156.
  • Uchegbu IF, Double JA, Turton JA, et al. Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitanmonostearate (span 60) niosomes in the mouse. Pharm Res. 1995;12(7):1019–1024.
  • Jigar V, Puja V, Krutika S. Formulation and evaluation of topical niosomal gel of erythromycin. Int J Pharm Pharm Sci. 2011;3(1):123–126.
  • Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and a sorbitantriester (span 85). Int J Pharm. 1994;105(1):1–6.
  • Singh CH, Jain CP, Kumar BN. Formulation, characterisation, stability and invitro evaluation of nimesulideniosomes. Pharmacophore. 2011;2(3):168–185.
  • Asthana GS, Asthana A, Singh D, et al. Etodolac containing topical niosomal gel: Formulation development and evaluation. JDD. 2016;16(1):8.
  • Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1–2):33–70.
  • Siddiqui N, Garg G, Sharma P. Fast dissolving tablets: preparation, characterisation and evaluation. Int J Pharm Sci. 2010;4(2):87–96.
  • Usama A, Fetih G, El-Faham T. Performance of meloxicam niosomal gel formulations for transdermal drug delivery. BJPR. 2016;12(2):1–14.
  • Swami H, Bilandi A, Kataria MK, et al. Formulation and Evaluation of Liposomal Gel of Lornoxicam. WJPR. 2015;4(9):2312–2338.
  • Kamboj S, Saini V, Bala S, et al. Formulation and characterization of drug loaded niosomal gel for anti-Inflammatory activity. IJMH. 2013;12(7):1–5.
  • Boushra M, El-Houssieny H, Hamouda M. Formulation and evaluation of clotrimazole from pluronic F127 gels. DDT. 2010;4(1):33–43.
  • Garg A, Aggarwal D, Garg S. Spreading of semisolid formulation. Pharm Tech. 2002;9(1):89–105.
  • Bhaskaran S, Panigrah L. Formulation and evaluation of niosomes using different non-ionic surfactants. Ind. J. Pharm. Sci. 2002;1(1):63–65.
  • Nagalakshmi S, Krishnaraj K, Arul Jothy M, et al. Fabrication and characterization of herbal drug –loaded nonionic surfactant based niosomal topical gel. J Pharm Sci Res. 2016;8(11):1271–1278.
  • Salih OS, Samein LH, Ali WK. Formulation and in vitro evaluation of rosuvastatin calcium niosomes. IJPPS. 2013;5(4):525–535.
  • Van-Abbe NJ, Nicholas P, Boon E. Exaggerated exposure in topical irritancy and sensitisation testing. J SocCosmet Chem. 1975;26(1):173–187.
  • Masumoto K, Matsumoto K, Yoshida A, et al. In vitro dissolution profile and in vivo absorption study of sustained release tablet containing chlorpheniramine maleate with water insoluble glucan. Chem Pharm Bull. 1984;32(9):3720–3723.
  • Bozzatto V, de Oliveira PR, Camargo-Mathias MI. Histopathology of the tegument of rabbits infested by rhipicephalussanguineus (acari: Ixodidae) ticks and exposed to selamectin (active principle of acaricide revolution, pfizer). Parasitol Res. 2013;112(7):2551–2560.
  • Germuth FG. A comparative histological and immological study in rabbits of induced hypersensitivity of the serum sickness type. J Exp Med. 1953;97(2):257–282.
  • Baroody FM. Nasal and paranasal sinus anatomy and physiology. Clin Allergy Immunol. 2007;19(1):1–21.
  • Arya S, Kumar VL. Anti-inflammatory efficacy of extracts of latex of calotropisprocera against different mediators of inflammation. Mediat Inflamm. 2005;2005(4):228–232.
  • Gartner LP, Hiatt JL. Colour textbook of histology e-book. Philadelphia: Elsevier Health Sciences. 2006. 2006(1).
  • Farshid AA, Tamaddonfard E, Morvaridi A. Effects of histidine and dexamethasone on the local inflammation induced by histamine in rats. Vet Res Forum. 2011;2(1):31–36.
  • Inoue H, Nagata N, Koshihara Y. Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear. Inflamm Res. 1996;45(7):316–323.
  • Tas C, Özkan Y, Savaser A, et al. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. Farmaco. 2003;58(8):605–611.